Outlook on the CBD Industry in the United States to 2024 - Removal of Hemp from Controlled Substance Act is Driving Growth
January 21, 2021 09:58 ET
|
Research and Markets
Dublin, Jan. 21, 2021 (GLOBE NEWSWIRE) -- The "The US Cannabidiol (CBD) Market: Size & Forecasts with Impact Analysis of COVID-19 (2020-2024 Edition)" report has been added to...
The Jordre Well, LLC Submits CBD-Infused Coffee Samples to Labs for Testing
January 21, 2021 09:25 ET
|
Coffee Holding Co., Inc.
STATEN ISLAND, New York, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Coffee Holding Co., Inc. (Nasdaq: JVA) (the “Company”), a leading integrated wholesale coffee roaster and dealer in the United States,...
Canapar Welcomes RAMM Pharma as Strategic Shareholder; Closes $6,427,000 Financing
January 20, 2021 09:48 ET
|
Canapar Corp.
RAGUSA, Italy, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Canapar Corp. (“Canapar”) and RAMM Pharma Corp. (including its wholly owned subsidiaries, "RAMM") (CSE: RAMM) are pleased to announce they have...
North America Hemp-derived Cannabidiol (CBD) Markets, 2020-2027: Market Size is Expected to Reach USD 16.1 Billion, Rising at a CAGR of 27.7%
January 19, 2021 10:33 ET
|
Research and Markets
Dublin, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The "North America Hemp-derived Cannabidiol Market Size, Share & Trends Analysis Report by Product Type (Hemp-derived CBD Isolate, Hemp-derived CBD...
CannAssist International Xceptol Brand Approved and Included by RangeMe — Increasing SKUs and Providing Access to Over 10,000 Retailers
December 21, 2020 08:30 ET
|
CannAssist International Corp.
NEW YORK, Dec. 21, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CannAssist International Corp. (OTCQB: CNSC) ("CannAssist International" or the "Company") today announces its Xceptol brand approval...
InvestorBrandNetwork (IBN) Coverage Initiated for CannAssist International Corp.
December 10, 2020 08:30 ET
|
CannAssist International Corp.
NEW YORK, Dec. 10, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CannAssist International Corp. (OTCQB: CNSC), a biotechnological pharmaceutical and wellness company marketing the Xceptol consumer...
CV Sciences, Inc. Announces Closing of Committed Equity Financing Transaction
December 08, 2020 07:00 ET
|
CV Sciences, Inc.
SAN DIEGO, Dec. 08, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. Reports Third Quarter 2020 Financial Results
November 05, 2020 16:05 ET
|
CV Sciences, Inc.
SAN DIEGO, Nov. 05, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
United States $13.39 Billion Cannabidiol (CBD) Market to 2024 - Growth Drivers / Key Trends & Developments / Challenges
October 26, 2020 07:18 ET
|
Research and Markets
Dublin, Oct. 26, 2020 (GLOBE NEWSWIRE) -- The "US Cannabidiol (CBD) Market (by Types, Distribution Channels & Products): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)"...
CV Sciences, Inc. to Announce Third Quarter 2020 Results on November 5, 2020
October 23, 2020 07:00 ET
|
CV Sciences, Inc.
SAN DIEGO, Oct. 23, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...